Everads Therapy
PrivateLast Round
Grant
Feb 1, 2020
Total Funding Raised
$140,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Everads Therapy operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Grant round in February 2020.
Everads Therapy is a biotechnology company developing a novel delivery technology to treat retinal diseases via suprachoroidal administration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Everads Therapy Comparables
Compare Everads Therapy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clearside Biomedical, Inc. | 82% | |
| Re-Vana Therapeutics | 79% | |
| West Pharmaceutical Services, Inc. | 69% |
For institutional investors. Book with your work email.
Everads Therapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2020 | ||||
| Accelerator | Jan 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Everads Therapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Israel Innovation Authority | Grant |
| RAD BioMed | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 33% MoM.
- Jul 27, 2026
Monthly visitors grew 104% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
Everads Therapy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Everads Therapy's valuation, stock price, and market status.
Is Everads Therapy a public or private company?
Everads Therapy is a private company.
What is the current stock price of Everads Therapy?
Everads Therapy is a private company, so its shares have no public market price. Caplight tracks Everads Therapy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Everads Therapy worth (valuation)?
Valuation information for Everads Therapy is not publicly available.
Can I buy Everads Therapy stock?
Everads Therapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Everads Therapy's last funding round?
Everads Therapy's most recent funding round was Grant on February 1, 2020.
Who are the main investors in Everads Therapy?
Key investors in Everads Therapy include European Innovation Council Fund, Israel Innovation Authority, RAD BioMed.
Will Everads Therapy IPO soon?
No public IPO plans have been announced for Everads Therapy.
How can I track Everads Therapy secondary market activity?
Caplight tracks bids, offers, and trades in Everads Therapy's shares on secondary markets.